These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 35390085)

  • 1. The COVID-19 Vaccine: Trust, doubt, and hope for a future beyond the pandemic in Germany.
    Fiske A; Schönweitz F; Eichinger J; Zimmermann B; Hangel N; Sierawska A; McLennan S; Buyx A
    PLoS One; 2022; 17(4):e0266659. PubMed ID: 35390085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I want to be safe: understanding the main drivers behind vaccination choice throughout the pandemic.
    Marini M; Demichelis A; Menicagli D; Mancini G; Panizza F; Bilancini E; Cevolani G
    BMC Public Health; 2024 Apr; 24(1):1111. PubMed ID: 38649925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Influencing COVID-19 Vaccine Acceptance in High Income Countries Prior to Vaccine Approval and Rollout: A Narrative Review.
    Steffens MS; Bullivant B; Bolsewicz K; King C; Beard F
    Int J Public Health; 2022; 67():1604221. PubMed ID: 35250430
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination Hesitancy and Conspiracy Beliefs in the UK During the SARS-COV-2 (COVID-19) Pandemic.
    Bacon AM; Taylor S
    Int J Behav Med; 2022 Aug; 29(4):448-455. PubMed ID: 34599463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative insight into the perceptions and COVID-19 vaccine hesitancy among Pakistani pharmacists.
    Yaseen MO; Saif A; Khan TM; Yaseen M; Saif A; Bukhsh A; Shahid MN; Alsenani F; Tahir H; Ming LC; Amin MU; Suleiman AK; Al-Worafi YM; Baig MR; Saeed Imran M; Jaber AA
    Hum Vaccin Immunother; 2022 Dec; 18(1):2031455. PubMed ID: 35192781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trust in governments, public health institutions, and other information sources as determinants of COVID-19 vaccine uptake behavior in Japan.
    Cao A; Ueta M; Uchibori M; Murakami M; Kunishima H; Santosh Kumar R; Prommas P; Tomoi H; Gilmour S; Sakamoto H; Hashizume M; Naito W; Yasutaka T; Maruyama-Sakurai K; Miyata H; Nomura S
    Vaccine; 2024 Jun; 42(17):3684-3692. PubMed ID: 38714450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Political Ideologies, Government Trust, and COVID-19 Vaccine Hesitancy in South Korea: A Cross-Sectional Survey.
    Park HK; Ham JH; Jang DH; Lee JY; Jang WM
    Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Offering onsite COVID-19 vaccination to high-risk obstetrical patients: initial findings.
    Hirshberg JS; Huysman BC; Oakes MC; Cater EB; Odibo AO; Raghuraman N; Kelly JC
    Am J Obstet Gynecol MFM; 2021 Nov; 3(6):100478. PubMed ID: 34481996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracking Public Attitudes Toward COVID-19 Vaccination on Tweets in Canada: Using Aspect-Based Sentiment Analysis.
    Jang H; Rempel E; Roe I; Adu P; Carenini G; Janjua NZ
    J Med Internet Res; 2022 Mar; 24(3):e35016. PubMed ID: 35275835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence and determinants of COVID-19 vaccine hesitancy in the age of infodemic.
    Ouyang H; Ma X; Wu X
    Hum Vaccin Immunother; 2022 Dec; 18(1):2013694. PubMed ID: 35172676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 vaccine hesitancy - reasons and solutions to achieve a successful global vaccination campaign to tackle the ongoing pandemic.
    Dhama K; Sharun K; Tiwari R; Dhawan M; Emran TB; Rabaan AA; Alhumaid S
    Hum Vaccin Immunother; 2021 Oct; 17(10):3495-3499. PubMed ID: 34191680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prevalence of COVID-19 Vaccination and Vaccine Hesitancy in Pregnant Women: An Internet-based Cross-sectional Study in Japan.
    Hosokawa Y; Okawa S; Hori A; Morisaki N; Takahashi Y; Fujiwara T; Nakayama SF; Hamada H; Satoh T; Tabuchi T
    J Epidemiol; 2022 Apr; 32(4):188-194. PubMed ID: 35095091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What factors promote vaccine hesitancy or acceptance during pandemics? A systematic review and thematic analysis.
    Truong J; Bakshi S; Wasim A; Ahmad M; Majid U
    Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 34244738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.
    Hunter CM; Chou WS; Webb Hooper M
    Transl Behav Med; 2021 Jul; 11(7):1354-1358. PubMed ID: 34080616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
    Wiysonge CS; Ndwandwe D; Ryan J; Jaca A; Batouré O; Anya BM; Cooper S
    Hum Vaccin Immunother; 2022 Dec; 18(1):1-3. PubMed ID: 33684019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.